Daniel Romanelli, MD, an orthopedic sports medicine surgeon, has become the first surgeon in Texas to surpass 100 bridge-enhanced ACL restoration, or BEAR, implant procedures, according to a June 3 report from MegaDoctor News. Dr. Romanelli was also the first…
Biologics
Xtant Medical launched OsteoFactorPro, a naturally derived, growth factor-rich formulation for spine and orthopedics. OsteoFactorPro is designed to enhances the biologic activity and regenerative potential of any orthobiologic scaffold, according to a May 28 news release. It’s an off-the-shelf product…
Tetrous’ EnFix implant has been used in expanded applications beyond rotator cuff repair, according to a May 20 news release. Additional uses for the biologic implant proximal/distal biceps tenodesis, insertional Achilles tendinopathy, gluteus medius and proximal hamstring reattachment, lateral epicondyle…
Physicians at Huntington (N.Y.) Hospital, an affiliate of Northwell Health, have performed the first BEAR implant procedure and the first CartiHeal Agili-C implant procedure at the system. Robert Trasolini, DO, a sports medicine specialist at Northwell, performed the BEAR procedure…
Healthcare solutions provider Summit Products Group, based in Dallas, has launched a strategic partnership with regenerative medicine developer NovaBone Products. Summit focuses on cultivating a portfolio of products engineered for surgical applications, identifying breakthrough products and supporting their path to…
From product launches and milestones, here are five updates in orthobiologics since March 28. 1. Lenoss Medical’s OsteoPearl procedure reached its 150th case. OsteoPearl is an allograft designed to augment vertebral compression fractures. 2. Spine Wave released its Tempest demineralized…
CGBIO, a South Korea-based company, earned the FDA’s investigational device exemption approval for its Novosis putty for spinal fusions. The bone graft incorporates rhBMP-2 and is designed to enhance high-density bone formation and minimize ectopic bone growth, according to a…
A study reporting on DiscGenics’ cell therapy phase 1 and 2 study has been selected as one of three of the best and most influential articles published in the International Journal of Spine Surgery in 2024. Here are four things…
Ventris Medical earned FDA clearance to use its Backpack bone graft in intervertebral disc space. The bone graft earned its first FDA nod in January. Backpack is offered in two versions — one with Allocell AF allograft fibers and one…
Spine Wave released its Tempest demineralized cortical fibers in a full-market release. The launch marks the company’s push into the cortical fiber segment of the spinal allograft market, according to an April 9 news release. Tempest is made entirely of…
